Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
03/29/2007 | DE102005046592A1 New 2-substituted pyrimidine derivatives, useful for controlling phytopathogenic fungi and for controlling animal pests in agriculture |
03/29/2007 | CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
03/29/2007 | CA2622642A1 Dipeptidyl peptidase inhibitors |
03/28/2007 | EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
03/28/2007 | EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy |
03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
03/28/2007 | EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
03/28/2007 | EP1765790A1 Azine-carboxamides as anti-cancer agent |
03/28/2007 | EP1765777A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
03/28/2007 | EP1765768A1 Substituted acids for the treatment of respiratory diseases |
03/28/2007 | EP1765760A1 Phenyl derivatives comprising an acetylene group |
03/28/2007 | CN1938285A 4-anilinequinazolines with adenosine-kiase inhibitor properties |
03/28/2007 | CN1938284A Chemical process |
03/28/2007 | CN1938280A Thiourea compositions and uses thereof |
03/28/2007 | CN1938244A Fluoridation method |
03/28/2007 | CN1937921A 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same |
03/28/2007 | CN1937919A Difluoromethanesulfonyl anilide derivatives useful as herbicides |
03/28/2007 | CN1935805A Pyrimidine derivative compound and its preparing method |
03/28/2007 | CN1935793A Process for producing substituted aniline compound |
03/28/2007 | CN1935792A Process for producing substituted aniline compound |
03/28/2007 | CN1935780A Process for producing substituted aniline compound |
03/28/2007 | CN1307187C Method for preparing Rosuvastain and its intermediate |
03/28/2007 | CN1307173C Pyrimidineamines as angiogenesis modulators |
03/27/2007 | US7196200 5-oxo-5,8-dihydro[2,3-d]pyrimidinopyridine-6-carboxylic acids or 7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors |
03/27/2007 | US7196194 for color photography |
03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
03/27/2007 | US7196091 Tyrosine kinase inhibitors; controlling signal transduction; antitumor agents; benign prostate hyperplasia; respiratory system disorders |
03/27/2007 | US7196089 Administering to a patient a furan ring containing compound as prostaglandin E4 receptor antagonist to treat various diseases, such as migraines and headache |
03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
03/27/2007 | US7196086 Substituted dihydroquinazolines |
03/27/2007 | US7195879 Method for identifying modulators of NAv ion channels |
03/27/2007 | CA2208018C Sulfonamides |
03/27/2007 | CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | WO2007031829A2 Novel pyrimidine carboxamides |
03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
03/22/2007 | WO2007031524A1 Pesticide pyrimidinyloxy substituted phenylamidine derivatives |
03/22/2007 | WO2007031208A2 A use of sulfonanilides as herbicide |
03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
03/22/2007 | US20070066822 Ionic liquids |
03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
03/22/2007 | US20070066622 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses |
03/22/2007 | US20070066605 Fungicides |
03/22/2007 | US20070066586 Aniline derivatives |
03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
03/22/2007 | CA2622578A1 A use of sulfonanilides as herbicide |
03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | CA2619064A1 Pesticide pyrimidinyloxy substituted phenylamidine derivatives |
03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
03/21/2007 | EP1763518A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
03/21/2007 | EP1763517A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
03/21/2007 | EP1763514A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
03/21/2007 | EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines |
03/21/2007 | CN1934213A Material for organic electroluminescence device and organic electroluminescence device utilizing the same |
03/21/2007 | CN1934111A Heteroaryl-fused pyrazolo derivatives |
03/21/2007 | CN1934093A Pyrimidyl phosphonate antiviral compounds and methods of use |
03/21/2007 | CN1933839A Compounds and methods of use |
03/21/2007 | CN1931846A Alcohol amide condensed ester compound and its prepn and use |
03/21/2007 | CN1305860C Condensed quinazoline derirative used as tyrosine kinase inhibitor |
03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
03/20/2007 | US7193108 Phenylpropionic acid derivatives |
03/20/2007 | US7193080 Color photography |
03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
03/20/2007 | US7192969 Ester derivatives |
03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
03/20/2007 | US7192948 Bicyclic heterocycles as HIV integrase inhibitors |
03/20/2007 | US7192572 Compound delivery systems |
03/15/2007 | WO2007029251A2 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
03/15/2007 | WO2007028789A1 Quinazoline derivatives as antiviral agents |
03/15/2007 | WO2007028424A1 Amide derivatives as ppar activators |
03/15/2007 | US20070060608 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
03/15/2007 | US20070060601 Mitotic kinesin inhibitors |
03/15/2007 | US20070060600 4-Anilinequinazolines with adenosine-kiase inhibitor properties |
03/15/2007 | CA2621111A1 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase |
03/15/2007 | CA2597148A1 Amide derivatives as ppar activators |
03/14/2007 | EP1761543A1 Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same |
03/14/2007 | EP1761540A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
03/14/2007 | EP1562936B1 Therapeutic piperazine compounds |
03/14/2007 | EP1284968B1 Method of combating undesired plant growth on cereals |
03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
03/14/2007 | CN1930166A 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds |
03/14/2007 | CN1930165A 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
03/14/2007 | CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents |
03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
03/14/2007 | CN1930139A Derivatives of hydroxamic acid as metalloproteinase inhibitors |
03/14/2007 | CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
03/14/2007 | CN1930134A Use of pyrimidine compounds in the preparation of parasiticides |
03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
03/14/2007 | CN1927839A Compound of 1,4-di(arylamido substituted alkylamino)-5,8-dihydroxyanthraquinone and preparation method thereof |
03/14/2007 | CN1304394C Diastereomeric selective preparation method of lamivudine |
03/14/2007 | CN1304391C Preparation method of hydrobromic acid antifebrile dichroanone |
03/13/2007 | US7189864 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors |
03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |